We offer several patient support programs. See the information below to find out if any of our programs may help you.
Please type in a product name to see if you're financially eligible.
We have program(s) available for this product:
We have programs that offer information and potential financial support for our products, including a program that provides certain medicines or adult vaccines free of charge, to eligible patients in the U.S.
Select Merck brands offer coupons to eligible, privately-insured patients to save on their out-of-pocket costs. To see if a coupon is available, please go to the product brand website. Coupons are not available for patients who are uninsured or patients with Medicare or other Government Program insurance. Other eligibility restrictions and Terms and Conditions apply.
The Merck Access Program may be able to help answer questions related to insurance coverage and financial assistance options for certain Merck products including questions about:
The Merck Patient Assistance Program provides certain medicines and adult vaccines free of charge to eligible individuals who do not have insurance or whose insurance does not cover their prescription Merck products.
Copyright © 2024 Merck & Co., Inc., Rahway, NJ USA, and its affiliates. All rights reserved. | This site is intended only for residents of the United States and Canada.
This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
